Contact Us (781) 301-7474

Investors

Hemanext has committed its resources to the continuing effort of the transfusion medicine community to save lives and improve patient outcomes. The company is dedicated to improving the quality, safety, efficacy, and cost of transfusion therapy.

Resources

View Investor Portal for confidential information and updates. Learn about Hemanext ONE technology.

Investment Opportunities

New Investor? Click to Sign-up

Hemanext ONE®

News Updates

Hemanext Partners with Sickle Cell 101 to Sponsor Sickle Cell Education

Hemanext Inc. a privately held, US-based medical technology company dedicated to improving the quality, safety, efficacy, and cost of red blood cell (RBC) transfusions, has partnered with Sickle Cell 101 (SC101), a Silicon Valley-based non-profit, to sponsor and promote sickle cell disease (SCD) education.

Hemanext to Present New Red Blood Cell Research Data at AABB 2020

Hemanext Inc., a privately held medical technology company dedicated to improving the quality, safety, efficacy and cost of red blood cell (RBC) transfusions, today announced that it will present four new abstracts on the potential benefits of hypoxic storage of RBCs through its online booth during the American Association of Blood Banks (AABB) Virtual Annual Meeting Oct. 3-5, 2020.

Thalassaemia International Federation and Hemanext® Inc. Announce New Strategic Alliance

The Thalassaemia International Federation (TIF), a worldwide organization dedicated to ensuring equal access to quality healthcare for every patient with thalassaemia and other hemoglobin disorders across the world, and Hemanext Inc., a privately held medical technology company dedicated to improving patients’ quality of life by delivering a better red blood cell (RBC) replacement therapy, today announced a new strategic alliance on behalf of people living with thalassaemia.

Additional Information

Curated resources for news, contact information, and newsletter sign-up.

Privacy


We use cookies to understand how you use our site and to improve your experience. This includes personalizing content. To learn more, click here.